In humans there is evidence that in utero exposure to cigarette smoke results in decreased fertility in female offspring. We have demonstrated in rats that fetal and neonatal exposure to nicotine alone results in impaired fertility and increased follicular atresia in the adult female offspring. In mammals, the insulin-like growth factor-I and -II (IGF-I and -II) and their binding proteins (IGFBPs) are considered stimulators and inhibitors of follicular growth and maturation. Therefore we hypothesized that dysregulation of the intra-ovarian IGF system could be implicated in the impaired fertility observed in nicotine-exposed offspring. Nulliparous female Wistar rats were exposed to nicotine (1 mg/kg/d) for 2 weeks prior to mating until weaning. Ovaries were collected on the morning of estrus from sexually mature saline-and nicotine-exposed offspring. Protein expression of IGF ligands and receptors (IGFR-I and IGFR-II) were quantifi ed by western blot and immunohistochemistry. The expression of IGF-I, IGF-II; IGFR-I, IGFR-II; and IGFBP1-6 mRNA in the ovary was determined by semi-quantitative reverse transcriptase-PCR. Results showed that nicotine exposure signifi cantly reduced IGF-I, IGF-II and IGFR-I protein expression (p Ͻ 0.01) relative to saline controls. Furthermore, nicotine-exposed offspring had signifi cantly reduced IGFR-II mRNA expression (p Ͻ 0.01) in the ovary. Data from this study suggest that the decreased fertility and increased follicular atresia in nicotine-exposed animals may be due, in part, to disruption of IGF regulation in the ovary.
Introduction
It has been well documented that cigarette smoking is one of the most important and modifi able risk factors associated with impaired fertility in adult females. 1 Cigarette smoking is thought to affect female fertility via a number of alterations in ovarian function, including abnormal steroidogenesis, depleted ovarian reserves and increased frequency of oocyte chromosomal abnormalities. [2] [3] [4] [5] [6] However what is less well known is that fetal and neonatal exposure to cigarette smoke can lead to impaired fertility in the offspring. Indeed, population based studies have also revealed an association between fetal exposure to cigarette smoke and compromised fertility in adulthood. 7, 8 However, the precise mechanism by which this phenomenon occurs remains unknown.
Of the over 4000 chemicals contained in cigarette smoke, 9 the compound(s) responsible for these adverse effects remains elusive, although animal studies suggest that nicotine, the major addictive component of cigarette smoke, may play an important role. Our laboratory has previously shown in a rat model that maternal exposure to nicotine during pregnancy and lactation results in reduced fertility, dysregulation of ovarian steroidogenesis, and altered follicle dynamics in the female offspring at six months of age compared to saline-exposed controls. 10 Although the mechanism by which prenatal nicotine exposure can adversely impact postnatal ovarian function is unknown, the change in follicle dynamics and decline in follicle health suggests that growth factors in the ovary may be affected.
Within the ovary, follicle growth, follicle differentiation, follicle maturation, release of viable oocyte and the formation and regression of the corpus luteum are precisely controlled by the coordinated regulation and action of the gonadal steroid hormones as well as factors that stimulate cellular proliferation and differentation and those that inhibit these processes. Among potential intra-ovarian regulators, insulin-like growth factor has been widely studied and appears to serve as a central signal of a complete intra-ovarian growth factor system. The IGF family includes the IGF ligands (IGF-I and -II), type 1 and 2 IGF receptors (IGFR-I, -II), at least 6 high affi nity binding proteins (IGFBP1-6) and IGFBP-directed endopeptidases.
11 These components are critical for normal ovarian function and indeed studies have demonstrated that the loss of IGF-I in vivo in animal models is associated with impaired ovulation and sterility. 12 Cigarette smoking in adults has been associated with decreased serum IGF-I levels 13, 14 and with decreased IGF-I levels in cord plasma of babies born to mothers who smoked. 15 Furthermore, the results from animal studies have demonstrated that the IGF axis is sensitive to perturbations during fetal life as chemical insults and metabolic stressors, including nicotine, have been shown to alter expression of key components of the IGF system in numerous organ systems postnatally. [16] [17] [18] [19] [20] Therefore the dysregulation of the intra-ovarian IGF system as a result of fetal and neonatal exposure to nicotine could have signifi cant implications on ovarian function postnatally. The goal of this study was 1) to determine whether the observed reduction in fertility in nicotine-exposed offspring can be explained by dysregulation of the intra-ovarian IGF system and 2) determine whether the ability of nicotine to alter the intra-ovarian IGF system is via the nicotinic acetylcholine (nAChR) receptors in the fetal and neonatal ovary.
Materials and Methods

Maintenance and treatment of animals
All animal experiments were approved by the Animal Research Ethics Board at McMaster University, in accordance with the guidelines of the Canadian Council for Animal Care. Nulliparous 200-250 g female Wistar rats (Harlan, Indianapolis, IN, U.S.A.) were maintained under controlled lighting (12:12 L:D) and temperature (22 °C) with ad libitum access to food and water. Two weeks prior to mating the dams were randomly assigned to receive either saline (vehicle) or nicotine (n = 7 per group). Dams were injected subcutaneously with 1 mg/kg/day nicotine bitartrate (Sigma Aldrich, St. Louis, MO, U.S.A.) or saline for 14 d prior to mating, during pregnancy and post-partum until weaning. The dose of nicotine used in this study (1 mg/kg per day nicotine bitartrate) results in maternal serum cotinine concentrations of 136 ng/ml, 10 which is within the range of cotinine levels (80-163 ng/ml) reported in women who are considered as 'moderate smokers.' 21 In addition, this dose of nicotine resulted in serum cotinine concentrations of 26 ng/ml in the nicotine-exposed offspring at birth, 10 which is also within the range (5-30 ng/ml) observed in infants nursed by smoking mothers. 22 Litter size was culled to eight at birth (postnatal day 1; PND1) to assure uniformity of litter size between treated (nicotine) and control (saline) litters. After weaning (postnatal day 21; PND21), female offspring were selected randomly and caged as sibling pairs. To examine whether nicotine could act directly at the fetal and neonatal ovary, ovaries were collected at PND1 and PND21, frozen in liquid nitrogen and analyzed by RT PCR to determine if nAChR subunits are present.
Beginning at 6 months of age, vaginal swabs were performed daily to determine the time of estrous. In the morning of estrus, animals were sacrifi ced by CO 2 asphyxiation. Blood samples were collected, allowed to clot at 4 °C, centrifuged, and stored at −80 °C. Ovaries were excised; one frozen in liquid nitrogen and stored at −80 °C, the other fixed in 10% neutral buffered formalin, embedded in paraffi n and sectioned for immunohistochemistry.
RT PCR
Expression of nAChR subunits (α2, α3, α4, α5, α6, α7, β2, β3, β4) and components of the IGF system (IGFI, IGFII, IGFR-I, IGFR-II, IGFBP1-6) were determined by semi-quantitative RT-PCR using previously published primer sequences. [23] [24] [25] Total RNA was extracted from the frozen ovarian tissue using RNeasy Mini Kit (Qiagen, Mississauga, ON, Canada) according to manufacturer's instructions. RNA samples were demonstrated to have intact 18s and 28s RNA bands on ethidium bromide-stained agarose gels. RNA samples (n = 5 per group) were reverse-transcribed to cDNA in a 20 μL reaction mixture containing 1 μg of extracted RNA, 1 μl of random primers, 1 μl of dNTPs (10 mM), 4 μl of 5X First-Strand Buffer, 1 μl of 0.1M DTT, 1 μl of RNase OUT,1 μl of Superscript III RT, and DNase/RNase free water (Invitrogen, Carlsbad, CA, U.S.A.), according to the standard protocol supplied with each product. The reaction was carried out in an iCycler thermal cycler (Bio-Rad, Hercules, CA, U.S.A.) using the following program: primer annealing for 5 min at 25 °C, RT for 60 min at 50 °C, and inactivation reaction for 15 min at 70 °C. The cDNA was stored at −20 °C until use. cDNA was subjected to PCR with a total reaction volume of 50 μL using primers listed in Table 1 . All amplifi cations were performed in the iCycler thermal cycler (Bio-Rad, Hercules, CA, U.S.A.) using 48 μL Platinum Blue PCR Supermix (Invitrogen, Carlsbad, CA, U.S.A.), 1 μL of template cDNA, and 1 μL of primer mix (10 μM; MOBIX, McMaster University, Hamilton, ON, Canada). After initial denaturation/enzyme activation step at 94 °C for 2 minutes, 35 cycles of PCR were performed under the following conditions: denaturing at 94 °C for 30 sec, annealing at 55 °C for 30 sec, extension at 72 °C for 1 min/kb. Electrophoresis analysis was conducted on a 3% agarose gel stained with 1.875 μl ethidium bromide (EMD, Gibbstown, NJ, U.S.A.). PCR products were visualized with the Epi Chemi II Darkroom and Labworks software (UVP Inc., Upland, CA, U.S.A.), and with the use of a 100 bp DNA ladder specifi c gene products were confi rmed. The optical density of the samples was measured and after being normalized to a housekeeping gene (lamin or β-actin), the mRNA expression of the genes of interest was compared between treatment groups.
Immunohistochemistry
Protein expression of IGF-I and IGF-II, in salineand nicotine-exposed ovarian sections was determined using immunohistochemistry. Histological tissue sections (5 μm) were cut from paraffi n embedded sections using a rotary microtome. Briefl y, tissues were deparaffi nized and rehydrated and antigen retrieval was performed by immersion in 10 mM Citrate buffer (90 °C) for 12 minutes. 
Results
Expression of nAChR subunits in neonatal ovarian tissue
At PND1 and PND21 all of the nAChR subunits except α5 were present in the ovary of both salineand nicotine-exposed offspring (Fig. 1) .
Protein expression of intra-ovarian IGF axis components Fetal and neonatal exposure to nicotine caused signifi cant changes in components of the intraovarian IGF system. Both IGF-I and II were expressed in ovarian stoma, theca and granulosa cell compartments (Fig. 2) . The IGF ligands (IGF-I and IGF-I) were signifi cantly (p Ͻ 0.05) decreased in nicotine-exposed offspring (Fig. 2) . Loss of expression of IGF-I and -II occurred in all ovarian cell compartments and the loss did not appear elevated or reduced in any compartment compared to the others. IGFR-I protein expression was signifi cantly decreased in the nicotine exposed ovaries (Fig. 3A , p Ͻ 0.05), whereas there was no effect of the nicotine exposure on the expression of IGFR-II (Fig. 3B ).
mRNA expression of the intra-ovarian IGF axis components Fetal and neonatal exposure to nicotine did not affect the gene expression of the two IGF ligands, nor did it affect the expression of any of the six IGF binding proteins. Fetal and neonatal exposure to nicotine did signifi cantly (p Ͻ 0.01) decrease IGFR-II mRNA but did not alter IGFR-I mRNA expression ( Table 2) .
Discussion
In the past few decades there has been an increased concern globally that fetal exposure to environmental chemicals is resulting in adverse health consequences in offspring. These concerns have largely focused on reproductive disorders and infertility as chemical insults in utero have been shown to cause impaired postnatal fertility. [26] [27] [28] [29] [30] The majority of previous research has focused on compounds with estrogenic activity including polychlorinated biphenyls, herbicides, chlorinated hydrocarbon pesticides and plasticizers. More recently there has been an increased interest in the reproductive health consequences to the offspring as a result of maternal lifestyle choices, such as smoking. 8 Epidemiological studies have shown an association between maternal smoking and reduced fertility in the female offspring in adulthood although the mechanisms are unknown. 7, 31 Results from in vivo and in vitro studies have clearly shown that nicotine alone can have adverse effects on adult ovarian function, including an increased number of atretic follicles, reduced ovarian and uterine weights, and irregularities in the estrous cycle 32, 33 Nicotine has been shown to cross the placenta and accumulates in breast milk during lactation resulting in both fetal and neonatal exposure to nicotine 34 We have previously demonstrated in our rat model that prenatal and lactational exposure to nicotine results in reduced fertility in the female offspring at 6 months of age as well as altered follicle dynamics resulting in increased atresia of growing follicles 10 Because a loss of IGF-I in vivo has been associated with impaired ovulation and sterility and cigarette smoke has been associated with reduced IGF-I serum levels [12] [13] [14] [15] we hypothesized that the reduced fertility seen in the nicotine-exposed female offspring is due to alteration in the intra-ovarian IGF system.
In this study, we have shown that nicotineexposed animals have decreased expression of IGF-I and IGF-II, and the IGFR-I at the same age where we have previously observed decreased fertility and increased follicle atresia. 10 In the ovary, IGF-I and to a lesser degree IGF-II bind to the IGFR-I to stimulate follicle growth and maturation. IGF-I activity has previously been detected in the granulosa cells of healthy follicles but, in contrast, expression of IGF-I mRNA is not observed in atretic follicles. 35 In response to nicotine exposure, a decrease in IGFR-II was detected, while IGFR-I was unchanged, Conversely, at the protein level, IGFR-I was decreased while IGFR-II was not different. The reason for this discrepancy is not clear, but likely involves changes in transcriptional regulation of the IGF receptors, or changes in receptor mRNA stability. Nicotine has been shown to increase gene transcription of pro-enkephalin in bovine chromaffin cells 36 and alters tyrosine hydroxylase mRNA stability in rodent vascular cells. 37 Although the effects of nicotine on IGF gene transcription or mRNA stability have not been studied to date, it is likely that nicotine does alter gene and protein expression through these mechanisms. Studies have also shown that IGFs not only stimulate ovarian cell growth, but are also are responsible for the attenuation of apoptotic cell death that occurs at various stages of follicle development. 12, 38 In bovine ovaries, IGF availability and the expression of IGFBPs have been suggested to play a role in determining whether a follicle will progress to dominance and ovulate or succumb to atresia. 38 A reduction in IGF signaling in the ovary of the nicotine-exposed females may therefore be suffi cient to explain the reduced number of growing follicles and impaired fertility we have previously reported. 10 The IGFs have been shown to be involved in follicle selection, dominance, and ovulation and reduced IGF expression is associated with decreased ovulatory events. 35, 39 It is possible that nicotine, acting via the nAChR in the ovary directly initiated a change in key components of the intra-ovarian IGF axis. However, the mechanism by which fetal and neonatal exposure to nicotine can permanently alter the ovarian IGF axis is currently unknown.
The consequence of a dysregulated intra-ovarian system may extend beyond altered follicle growth and dynamics, as the ovarian steroidogenic pathway is modifi ed by a number of growth factors including IGF-I and IGF-II. IGF-I has been shown to stimulate basal and FSH-supported synthesis of progesterone, estrone and androgens by granulosa and theca cells. [40] [41] [42] [43] The stimulatory effects of IGFs on steroidogenic cells have been attributed to increased cAMP generation and enhanced uptake of lipoproteins. 44 Moreover, it has been shown that IGF-I can also affect ovarian steroidogenesis by increasing the activity and expression of key steroidogenic enzymes including steroid acute regulatory protein (StAR), 42 cholesterol side-chain cleavage cytochrome P450 (CYP11A1), 41, 45 3β-hydroxysteroid dehydrogenase (3β-HSD) 41, 46 and aromatase (CYP19A1). 47 Whether these key steroidogenic enzymes are altered in our animal model as a result of changes in the expression of the IGF system is currently under investigation.
One-fi fth of pregnant women smoke. 48 Results from this study have shown that maternal nicotine use resulting in prenatal and lactational exposure to nicotine may cause alterations in the intra-ovarian IGF system, providing a potential mechanism behind the decreased fertility seen in the adult offspring. Increasingly, pregnant women who are unable to quit smoking are encouraged to use nicotine replacement therapy (NRT), even though the safety of this practice has not been well studied. Although there are no reports of decreased fertility in NRT exposed children, evidence from this study raises concerns about the long-term health effects of NRT and nicotine product use during pregnancy.
